Literature DB >> 16723853

Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma.

Seung-Mo Hong1, Alison E Presley, Edward B Stelow, Henry F Frierson, Christopher A Moskaluk.   

Abstract

The histologic boundaries of the extrahepatic bile ducts (EBDs) are not well defined, despite the fact that pathologic staging of carcinomas arising in these structures requires the determination of extent of tumor invasion in this area. Perhaps in part, because the smooth muscle band in the EBD wall is not well formed throughout the length of these structures, a previous definition of the outer portion of the bile duct wall included "loose, richly vascularized connective tissue, interlaced with large nerve fibers." We have experienced difficulty in the application of these criteria in staging EBD carcinomas, which requires the histologic determination of the extent of the EBD wall. To systematically study the histologic features of EBD tissue boundaries, 34 EBD specimens obtained from autopsy were analyzed with attention to the distribution of blood vessels and nerve fibers along the length of this system. The EBD specimens were divided into lower, middle, and upper portions, and the locations of blood vessels and nerve fibers were then analyzed separately at each location. We defined the fibromuscular wall as the dense concentric arrangement of collagen and smooth muscle fibers surrounding the EBD mucosa. The location of blood vessels and nerve fibers was categorized as either (1) within, (2) junctional to, or (3) outside of the fibromuscular wall. Blood vessels and nerve fibers are located predominantly outside of the fibromuscular wall and are usually surrounded by adipose tissue throughout the entire EBD, however, their distribution in this location is not consistent. Because of these histologic features, we propose that the bile duct wall is more precisely defined as occurring between the mucosa and the outermost boundary of dense fibromuscular tissue, without consideration of the presence or absence of blood vessels and nerve fibers.

Entities:  

Mesh:

Year:  2006        PMID: 16723853     DOI: 10.1097/00000478-200606000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Is it possible to define early distal cholangiocarcinoma?

Authors:  Fumihiko Miura; Keiji Sano; Hodaka Amano; Naoyuki Toyota; Keita Wada; Takuo Tokairin; Fukuo Kondo; Koichi Hayano; Hisahiro Matsubara; Tadahiro Takada
Journal:  Langenbecks Arch Surg       Date:  2015-10-30       Impact factor: 3.445

2.  Evaluation of UICC-TNM and JSBS staging systems for surgical patients with extrahepatic cholangiocarcinoma.

Authors:  Ryoko Sasaki; Soichiro Murata; Tatsuya Oda; Nobuhiro Ohkohchi; Yuichiro Takeda; Go Wakabayashi
Journal:  Langenbecks Arch Surg       Date:  2010-04-01       Impact factor: 3.445

Review 3.  Staging of extrahepatic cholangiocarcinoma.

Authors:  Yong Eun Chung; Myeong-Jin Kim; Young Nyun Park; Yoon-Hee Lee; Jin-Young Choi
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

4.  Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.

Authors:  Seung-Mo Hong; Timothy M Pawlik; Hyungjun Cho; Bhuvnesh Aggarwal; Michael Goggins; Ralph H Hruban; Robert A Anders
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

5.  Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree Approach.

Authors:  Kyueng-Whan Min; Dong-Hoon Kim; Byoung Kwan Son; Eun-Kyung Kim; Sang Bong Ahn; Seong Hwan Kim; Yun Ju Jo; Young Sook Park; Jinwon Seo; Young Ha Oh; Sukjoong Oh; Ho Young Kim; Mi Jung Kwon; Soo Kee Min; Hye-Rim Park; Ji-Young Choe; Jang Yong Jeon; Hong Il Ha; Jung Woo Lee
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 6.  Early bile duct cancer.

Authors:  Jae Myung Cha; Myung-Hwan Kim; Se Jin Jang
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

7.  Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma.

Authors:  Sun-Young Jun; You-Na Sung; Jae Hoon Lee; Kwang-Min Park; Young-Joo Lee; Seung-Mo Hong
Journal:  Cancer Res Treat       Date:  2018-03-02       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.